Joung Sandy, Wei Janet, Nelson Michael D, Aldiwani Haider, Shufelt Chrisandra, Tamarappoo Balaji, Berman Daniel, Thomson Louise E J, Bairey Merz C Noel
Barbra Streisand Women's Heart Center, Cedars-Sinai Heart Institute, 127 S. San Vicente Blvd, Suite A3600, Los Angeles, CA, 90048, USA.
Applied Physiology and Advanced Imaging Laboratory, Arlington, TX, 76019, USA.
J Med Case Rep. 2019 May 6;13(1):134. doi: 10.1186/s13256-019-2074-z.
In women with evidence of ischemia and no obstructive coronary artery disease the underlying mechanism is most often attributed to coronary microvascular dysfunction. Higher rates of adverse cardiovascular events, specifically heart failure with preserved ejection fraction, are present in women with coronary microvascular dysfunction, leading to the hypothesis that coronary microvascular dysfunction may contribute to the progression of heart failure with preserved ejection fraction. A 55-year-old, Caucasian woman with a past medical history of chest pain and shortness of breath was referred to our tertiary care center and diagnosed as having coronary microvascular dysfunction by invasive coronary reactivity testing. After 10 years of follow-up care for coronary microvascular dysfunction, she presented to an emergency room in acute heart failure and was diagnosed as having heart failure with preserved ejection fraction.
The current case report provides a specific example in support of existing studies that demonstrate that coronary microvascular dysfunction may be a precursor of heart failure with preserved ejection fraction. Further research is needed to establish causality and management.
Clinical Trial Registration: ClinicalTrials.gov Identifier: NCT02582021 .
在有心肌缺血证据但无阻塞性冠状动脉疾病的女性中,潜在机制通常归因于冠状动脉微血管功能障碍。冠状动脉微血管功能障碍的女性发生不良心血管事件的几率更高,尤其是射血分数保留的心力衰竭,这导致了一种假说,即冠状动脉微血管功能障碍可能促使射血分数保留的心力衰竭进展。一名55岁的白人女性,有胸痛和呼吸急促的既往病史,被转诊至我们的三级医疗中心,并通过有创冠状动脉反应性测试诊断为冠状动脉微血管功能障碍。在对冠状动脉微血管功能障碍进行10年的随访后,她因急性心力衰竭就诊于急诊室,被诊断为射血分数保留的心力衰竭。
本病例报告提供了一个具体例子,支持现有研究表明冠状动脉微血管功能障碍可能是射血分数保留的心力衰竭的先兆。需要进一步研究以确定因果关系和治疗方法。
临床试验注册:ClinicalTrials.gov标识符:NCT02582021 。